Spontaneous revertants of a temperature-sensitive Escherichia coli strain harboring a thermolabile valyl-transfer ribonucleic acid (tRNA) synthetase were selected for growth at 400C. Of these, a large number still contain the thermolabile valyl-tRNA synthetase. Three of these revertants contained an increased level of the thermolabile enzyme. The genetic locus, vaiX, responsible for the enzyme overproduction, is adjacent to the structural gene, valS, ofvalyl-tRNA synthetase. Determination (by radioimmunoassay) of the turnover rates of valyl-tRNA synthetase showed that the increased level of valyl-tRNA synthetase is due to new enzyme synthesis rather than decreased rates of protein degradation.
Aminoacyl-tRNA synthetases are enzymes of central importance for protein synthesis in cells. These enzymes are responsible for the correct attachment of each amino acid to its cognate tRNA (33) . In addition, through their catalysis of aminoacyl-tRNA esterification, the synthetases in bacteria are involved in the regulation of various biosynthetic operons (4) and of amino acid transport (32) , as well as in operation of the pleiotropic stringent response (5) .
Because these enzymes are involved in so many aspects of cellular metabolism (15) , the manner in which their levels are regulated is of great interest. In the past 10 years much work has been done in attempts to unravel the mechanisms by which the levels of aminoacyl-tRNA synthetases are controlled (23, 26) . Synthetase levels in bacterial cells have been found to vary in response to a variety of environmental factors, including carbon source in the growth medium (29) , growth temperature (17) , and restriction of cognate amino acids (26) .
Genetic alterations affecting the regulation of biosynthesis of several synthetases have been discovered. Mutants with increased levels of seryl-tRNA synthetase (8, 30, 35) , leucyl-tRNA synthetase (16, 35) , threonyl-tRNA synthetase (24, 27) , and methionyl-tRNA synthetase (6) have been found.
In this paper we describe the isolation and t The preceding paper in this series is by G. Theall, K. B. Low, and D. Soll (Mol. Gen. Genet. 169: [205] [206] [207] [208] [209] [210] [211] 1979 ). characterization ofEscherichia coli K-12 strains with genetic alterations leading to increased levels ofvalyl-tRNA synthetase. These strains were found among temperature-resistant revertants of a temperature-sensitive strain harboring a thermolabile valyl-tRNA synthetase. This type of selection procedure has been previously used successfully for obtaining E. coli mutants with increased levels of other aminoacyl-tRNA synthetases (23 Media. A modified Luria and Burrous (LB) medium and L agar were prepared as described previously (19) . For various growth curves and selection of transductants, minimal medium 56 was used (1) supplemented with any necessary growth factors such as thiamine (0.1 mg/ml), amino acids (each 100 ug/ml), purines and pyrimidines (each 40 ug/ml), and glucose (0.2%).
Revertant strains. Spontaneous temperature-resistant derivatives of strain MB1 were selected on LB agar at 400C. Portions (0.1 ml) were removed from a fresh 5-ml LB culture grown at 300C and plated on LB agar. The colonies which appeared after incubation at 40(C were picked, and markers were retested by replica plating (18) . The highest temperature at which a strain is able to grow is designated the growth limit of the strain. These were determined by replica plating and subsequent incubation at 25, 30, 37, 40, 42, and 45°C for 12 to 16 h.
Genetic manipulations. Bacterial crosses and transductions were done as previously described (18, 19) .
Preparation of cell extracts. Cells were grown and cell extracts were prepared as described previously (35) , except that after centrifugation the resulting supernatant fluid was dialyzed against buffer containing 30% polyethylene glycol, thus reducing the volume of the extract. Glycerol was added to a final concentration of 50%, and the mixture was stored at -200C. The extracts normally contained about 5 mg of protein per ml as determined by the method of Groves et al. (11) or Lowry et al. (20) with crystalline bovine plasma albumin as standard.
Preparation of tRNA. This was done as described previously (22) .
Aminoacylation reaction. Aminoacyl-tRNA synthetases were assayed at 25 or 30°C by the aminoacylation reaction as described earlier (32) . Enzyme activity was determined as picomoles of aminoacyltRNA formed per microgram of S-100 protein per minute.
Heat inactivation studies. Cell extracts, adjusted to a protein concentration of 1 mg/ml with bovine serum albumin in 10 mM sodium cacodylate (pH 7.2) -10% (vol/vol) glycerol, were incubated at 30 or 370C.
Aliquots were removed at various time intervals and assayed at 25°C for residual enzyme activity.
Antiserum preparation. Pure E. coli valyl-tRNA synthetase was used to prepare antibodies in a white New Zealand rabbit. Control antiserum was prepared from the blood of the rabbit before it had received injections of foreign proteins.
Antiserum titration by assay of residual activity. Cell extracts (each containing the same amount of protein of the strains to be compared) were mixed with a specified amount of wild-type cell extract diluted in a solution of 10 Assays of the amount of enzyme in any particular S-100 preparation were done in a similar fashion. It was determined that 50 A1 of a twofold dilution of S-100 protein (ca. 0.1 mg/ml) from a 5-ml cell sample (2 x 10' cells per ml) would inhibit the binding of 30 to 50% of the "MI-labeled antigen in the radioimmunoassay. Therefore, 50 p1 of a twofold dilution of each 5-ml S-100 cell sample to be assayed was added to the precoated wells of the microtiter plate as nonradioactive competitor antigen, and the procedure described above was carried out. From the percentage of 125I-labeled valyl-tRNA synthetase still binding to a well in the presence of nonradioactive S-100 protein as compared to the '2I radioactivity in wells with no nonradioactive S-100 protein, the concentration of the enzyme in an S-100 extract was obtained.
Preparation of labeled material for the monitoring of valyl-tRNA synthetase degradation in vivo. Bacterial cultures (30 to 40 ml) were grown at 28°C with aeration in minimal medium 56 supplemented with glucose (0.33%, wt/vol), Bi, and required amino acids. Upon reaching a cell density of 2 x 108 cells per ml, 0.1 mCi of [3H]lysine (specific activity, 50 to 60 Ci per mmol) was added per 10 ml of cell culture. After 5 min, 5 ml of the cell cultures were removed for the zero time readings and 22 ,mol of unlabeled lysine (a 2,600-fold excess) was immediately added as a chase. Samples (5 ml) of the cell cultures were removed thereafter at various times. Immediately upon its removal each sample was chilled. The cells were lysed in a French press, and S-100 extracts were prepared as described above.
Immunoprecipitation for the monitoring ofvalyl-tRNA synthetase degradation in vivo. ValyltRNA synthetase was isolated from the 3H-labeled S-100 preparation by immunoprecipitation. The procedure used is similar to that described by Hunter (13) .
The amount of the enzyme in each S-100 extract was first assayed by radioimmunoassay II. For each set of S-100 extracts (made from cell samples taken from the same culture), care was taken to add equal amounts of the enzyme to form the immunoprecipitate. 3H-labeled S-100 extract (50 to 100 pi) and rabbit anti-valyl-tRNA synthetase antiserum diluted in 0.01 M sodium phosphate (pH 7.5)-0.9% NaCl-0.1% BSA-0.01% sodium azide to make the total volume of 150 p1 were gently mixed together and allowed to sit for 1 h at room temperature. Then sheep anti-rabbit antiserum (150 pl) was added to each mixture. After 16 to 20 h at 40C, the precipitates were collected by centrifugation, washed with 0.01 M sodium phosphate (pH 7.4)-0.9% NaCl, and then dissolved in 0.05 M NaOH (0.5 ml). The 3H radioactivity was determined by liquid scintillation counting. Blank controls containing an equal amount of rabbit serum from an unimmunized rabbit in place of the anti-valyl-tRNA synthetase antiserum were always processed along with the experimental assay mixtures.
A competition assay to prove that the synthetase was indeed the protein precipitated in this assay was carried out by using the above-described procedure except that before addition of the 3H-labeled S-100 extract various dilutions of pure unlabeled enzyme were incubated for 1 h at room temperature with the anti-valyl-tRNA synthetase antiserum.
All assays were done in duplicate. The error in separate determinations was approximately 10%. The blank was generally 35 to 40% of the total radioactivity precipitated. This was always subtracted from the total radioactivity to give the net radioactivity precip- In vivo levels of valyl-tRNA. These were determined as described previously (34) .
Measurement of the amount of valyl-tRNA synthetase produced in various strains grown in different media. Cultures were grown at 28°C in LB medium or in minimal medium 56 containing vitamin Bl and required amino acids supplemented either with 0.33% glucose or with 1.0% disodium succinate. Upon reaching a cell density of 2 x 108 cells per ml, a 5-ml portion of cell culture was removed and immediately chilled, and the cells were harvested. After the cells were washed with 10 mM MgCl2-10 mM NH4Cl-10 mM Tris (pH 7.5), they were frozen at -78°C. S-100 preparations of these celLs were prepared in the above buffer. Thermosensitivity of valyl-tRNA synthetase in revertant strains. To determine whether these revertant strains still possessed the thermolabile enzyme of the parent strain MB1, standard heat inactivation studies of S-100 cell extracts were performed. Of 12 strains tested, 4 still contained a labile valyl-tRNA synthetase similar to that from parental strain MB1 (Fig. 1) . The valS+ strain MB2 is shown for purposes of comparison. The synthetases from the other eight strains also were found to be thermolabile, but less so than the parental (MB1) enzyme. This was, therefore, presumed to be due to second site mutations in the valS gene; these strains were not studied further.
Valyl-tRNA synthetase levels in revertant strains. The valyl-tRNA synthetase content ofthe S-100 extracts ofthese four revertants was determined by antiserum titration. Three strains, MB1381, MB1951, and MB2101, were found to have synthetase levels two to four times as high as the parent strain MB1 (Table 2) . A representative experiment is shown in Fig. 2 . At 370C, however, the synthetase-overproducing strains and strain MB2 grew approximately twice as fast in LB medium as strain MB1 grew at 30°C. Because of this growth rate difference, one might expect increased amounts of valyltRNA synthetase in the revertant strains compared to the temperature-sensitive parent (25) . However, no increased levels of the synthetase from cultures grown at 370C, as compared to 300C, were found in these strains (Table 2 ). This is in accord with the work of LeMaux et al. (17) . In fact, the amounts of valyl-tRNA synthetase in the revertant strains as compared to that in the parent strain MB1, although still greater than in MB1, were less so than they had been when all strains were grown at the same temperature (Table 2) . This is probably due to increased degradation of the thermolabile enzyme in the revertants grown at 370C as will be discussed below.
To rule out the possibility that the increased levels of synthetase observed by antiserum titration were caused by differences in antigenic determinants of the enzyme from various strains, their enzyme content was determined by radioimmunoassay. Comparison of the shapes of the radioimmunoassay curves obtained would be a measure of similarity of the antigenic de-J. BACTrERIOL. Various amounts of anti-valyl-tRNA synthetase antiserum were incubated with fixed amounts of S-100 cell extracts of strains grown at 30°C. After immunoprecipitation, the mixtures were assayed for their residual valyl-tRNA synthetase activity. An S-100 extract from strain MB2 (valS+) was assayed alone and was also added as a carrier in all assays of S-100 extracts from either the temperature-sensitive or revertant strains. 0, MB2; -0-, MB3121 + MB2; x, MBI + MB2; ---0---, MB1381 + MB2.
terminants of the various valyl-tRNA synthetases; curves of similar shape result from antigens with similar antigenic determinants (13). The radioimmunoassay curves (representative ones are shown in Fig. 3) showed similar shapes; thus the enzymes from all of the strains tested were antigenically similar. This experiment also confirmed the increased enzyme levels in three revertant strains and the lack of overproduction in strain MB3121 (Table 2) .
Due to the thermolability of the valyl-tRNA synthetase in the parent and revertant strains, the determination of valylation activity is not an accurate measure of the levels of this enzyme.
However, the observed (Table 2 ) synthetase activity in these strains supports the antiserum titration data.
tRNA levels in the revertant strains. Next, we wanted to determine whether elevated enzyme levels in some revertant strains would cause an increase in tRNAVal and also whether the revertant strain with normal levels is stabilized at the higher temperature by an increased tRNAv" concentration. Such a tRNA increase was observed in two temperature-resistant revertants of glutaminyl-tRNA synthetase (7, 22) . When the four revertant strains were assayed for the amounts of tRNAval, no increased level VOL. 139, 1979 .. O.
----- Levels of other aminoacyl-tRNA synthetases in the revertant strains. Are the levels of other aminoacyl-tRNA synthetases also elevated? When the activities of four other aminoacyl-tRNA synthetases in the aminoacylation reaction were determined, no significant increase of the enzymes for leucine, isoleucine, serine, and arginine was seen (data not shown). Thus the revertants appear to be selectively overproducing valyl-tRNA synthetase. Interestingly, neither leucyl-nor isoleucyl-tRNA synthetase is elevated, although evidence for the existence of a common control element in the regulation of production of branched-chain aminoacyl-tRNA synthetases has been presented (14) .
Genetic characterization of revertants. (Table 3) .
Examination of strains MB1 and MB2 and the revertants revealed that this set of isogenic strains harbors a cryptic auxotrophic mutation which could be overcome by the addition of isoleucine, valine, proline, argiine, and methionine to minimal medium. We therefore transduced one of the loci, valX12, causing overproduction of a temperature-sensitive valyl-tRNA synthetase into a genetically well-defined background. First, spontaneous uracil prototrophs were selected from the revertant strain MB1381 (vaiX12) from the parent strain MB1 (valS7) and from MB2 (valS+). P1 grown on these strains was transduced into strain NF269 (pyrB41 valS20), a strain nonviable at 400C, because of a thermolabile valyl-tRNA synthetase of intermediate thernolability in heat-inactivation assays. (The mutation in this strain, valS2O, is a different allele from that carried by strain MB1.) These transductions yielded Pyr+ strains MB5 (valS7), MB6 (valS+), and MB1383 (valS7 valX12). The highly thermolabile valyltRNA synthetae characteristic of strain MB1 was found in strains MB5 and MB1383, and thermostable valyl-tRNA synthetase was found in strain MB6 (data not shown). Strain MB1383 had approximately threefold more valyl-tRNA synthetase than strain MB5 (Table 4) . These three strains were used to study further the effects of the genetic alteration of synthetase production.
In vivo levels of valyl-tRNA and rate of protein synthesis. Since aminoacyl-tRNA synthetases are crucial for protein synthesis, any alterations of the enzymes themselves or in their levels should be mirrored in alterations in both rates of protein synthesis and in vivo levels of aminoacyl-tRNA. The rate of protein synthesis in these strains was measured by ["Cilysine incorporation at 28 and 33°C. Examination of the data (Table 5 ) reveals that the thermosensitive strain MB5 has a much decreased rate of protein synthesis at 33°C, while the wild-type strain MB6 and the overproducing strain MB1383 increased their rates of protein synthesis slightly. The slower rate of protein synthesis in strain MB5 is probably caused by lack of valyl-tRNA in vivo (Table 5 ). This is especially seen at 33°C, at which strain MB5 grew very poorly. Results represent the amount of antiserum required for 50% inactivation ofvalyl-tRNA synthetase activity.
Levels of valyl-tRNA synthetase in strains grown in different media. Many aminoacyl-tRNA synthetases are subject to metabolic control (21, 25, 29) . When an E. coli strain is grown in different media containing various carbon sources, both its growth rate and its aminoacyl-tRNA synthetase levels increase with the richness of the growth medium. In particular, valyl-tRNA synthetase levels have been shown to increase 2.5-fold over a 7-fold increase VOL. 139, 1979 on July 11, 2017 by guest http://jb.asm.org/ Downloaded from for the last 50 min of growth.
in growth rate (28) . Therefore we wanted to determine whether strain MB1383, a strain with altered valyl-tRNA synthetase levels, strain MB5, a strain with an altered valyl-tRNA synthetase enzyme, and wild-type strain MB6 would exhibit metabolic regulation of this particular synthetase.
The three strains were grown in LB, glucose miniimal, and succinate minimal media at 280C.
Their growth rates were monitored, and the levels of the synthetase were measured by radioimmunoassay II. Only a 2.4-fold growth rate difference was achieved (Table 6) by growing the strains in these media, whereas Parker et al. (28) had obtained a 6-fold growth rate difference by using the same carbon sources. This may be due to lower growth temperature (280C) or possibly to the nature of the strains themselves (acetate medium could not be used to extend the growth rate difference, as our strains showed no sign of growth in this medium after 4 days of incubation). However, the relative production of the synthetase among the three strains was nearly the same regardless of the growth medium. Strain MB1383 always appears to have an increased level of enzyme relative to strain MB5. There is generally a lower level of synthetase production in all three strains with growth in media poorer than LB. However, only the wildtype strain MB6 exhibits a parallel decrease in valyl-tRNA synthetase production with decrease in growth rate. Neither strain MB5 (valS7) nor strain MB1383 (valS7 valX12) do so; they do not follow the pattem of metabolic control described by Neidhardt et al. (25) . This may be due to the mutant nature of the enzyme and raises the question of whether synthetases are involved in their own control.
Degradation of valyl-tRNA synthetase in strains MB5, MB6, and MB1383. Mutant proteins are degraded much more rapidly than normal E. coli proteins (10, 31, 36 (Fig. 4) . The results (Fig. 5) duction of all the synthetases or even of just the branched-chain aminoacyl-tRNA synthetases has been observed. This is in accord with previous findings in E. coli that each regulatory mutation affects the production of only one synthetase (7, 8, 16, 35) . In addition, no link between synthetase production and production of the cognate tRNA has been found here.
The mutations leading to elevated levels of the synthetase in these three strains are closely linked to the valS gene. As such they are similar to serO (8) and leuX (16) in their relationship to their respective synthetase structural genes. However, further work must be done to determine whether the mutations are actually of the operator/promoter type as are serO and leuX.
The relationship between the various types of synthetase control mechanisms which have been found to give rise to increased levels of valyltRNA synthetase and the control mechanism which is genetically altered in these strains remains obscure. Experiments in which strains were grown in various media showed that the increased production of valyl-tRNA synthetase seen in a representative strain occurs independently of the growth medium. The increase does not seem to be a response of the mutant strain to a particular metabolite as was seen by Hirshfield and Zamecnik (12) in studies on lysyl-tRNA synthetase production.
A crucial and long-standing question in all studies on the regulation of aminoacyl-tRNA synthetase synthesis concerns the rates of protein turnover and new biosynthesis. By using _ _ _-VOL. 139, 1979 pure labeled valyl-tRNA synthetase and antiserum made against this protein, we have shown that the rates of valyl-tRNA synthetase degradation in the parent and in a representative temperature resistant revertant strain are similar. Thus the increased level of this enzyme found in the revertant strain is due to new synthesis. These experiments have also shown that the thermolabile valyl-tRNA synthetase isolated from the temperature-sensitive strain is more rapidly degraded than wild-type enzyme.
